{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:25:11Z","timestamp":1777001111860,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.leukres.2014.11.022","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T03:33:20Z","timestamp":1417491200000},"page":"170-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pilot study of erlotinib in patients with acute myeloid leukemia"],"prefix":"10.1016","volume":"39","author":[{"given":"Hamid","family":"Sayar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Czader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cangany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Konig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry D.","family":"Cripe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.11.022_bib0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bcp.2008.05.024","article-title":"Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison","volume":"76","author":"Boehrer","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2014.11.022_bib0010","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2007-07-100362","article-title":"Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study","volume":"111","author":"Boehrer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.022_bib0015","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.4161\/cc.10.18.16599","article-title":"Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia","volume":"10","author":"Boehrer","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2014.11.022_bib0020","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4161\/cc.22382","article-title":"Erlotinib antagonizes ABC transporters in acute myeloid leukemia","volume":"11","author":"Lainey","year":"2012","journal-title":"Cell Cycle"},{"issue":"November (11)","key":"10.1016\/j.leukres.2014.11.022_bib0025","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/leu.2013.89","article-title":"SYK regulates mTOR signaling in AML","volume":"27","author":"Carnevale","year":"2013","journal-title":"Leukemia"},{"issue":"November (2)","key":"10.1016\/j.leukres.2014.11.022_bib0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2013.10.082","article-title":"A critical role for Lyn in acute myeloid leukemia","volume":"441","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"May (18)","key":"10.1016\/j.leukres.2014.11.022_bib0035","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2013-05-505735","article-title":"Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells","volume":"123","author":"Cook","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.022_bib0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2007-01-069856","article-title":"Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer","volume":"110","author":"Chan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.022_bib0045","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1200\/JCO.2008.17.0357","article-title":"Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer","volume":"26","author":"Pitini","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2014.11.022_bib0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.23749","article-title":"Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes","volume":"89","author":"Komrokji","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2014.11.022_bib0055","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1038\/onc.2012.469","article-title":"Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia","volume":"32","author":"Lainey","year":"2013","journal-title":"Oncogene"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614003749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614003749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:53:48Z","timestamp":1538038428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614003749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0145212614003749"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.11.022","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study of erlotinib in patients with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}